Birthe Lykkegaard Hansen

Title: Innovations by Birthe Lykkegaard Hansen

Introduction

Birthe Lykkegaard Hansen, based in Værløse, Denmark, is a notable inventor with a remarkable portfolio of eight patents. Renowned for her contributions in the pharmaceutical sector, her inventions focus on formulations that address critical healthcare needs.

Latest Patents

One of Birthe's latest patents, titled "Pharmaceutical formulation," relates to aqueous pharmaceutical formulations comprising human growth hormone, histidine, poloxamer, phenol, and mannitol. This innovative formulation aims to enhance the stability and effectiveness of human growth hormone in therapeutic applications. Another significant patent is for "Stabilised solid compositions of factor VII polypeptides," which pertains to chemically and physically stable compositions that include Factor VII or a Factor VII-related polypeptide. These compositions can be conveniently stored, handled, and used at room temperature, making them especially valuable in clinical settings.

Career Highlights

Birthe is currently affiliated with Novo Nordisk Healthcare AG, a leading company specializing in diabetes care and hormone replacement therapies. Her work at Novo Nordisk highlights her commitment to advancing pharmaceutical solutions that can significantly improve patient outcomes.

Collaborations

Throughout her career, Birthe has collaborated with esteemed colleagues such as Michael Bech Jensen and Troels Kornfelt. These partnerships have undoubtedly contributed to her innovative endeavors and have reinforced her position as a key player in the pharmaceutical research community.

Conclusion

Birthe Lykkegaard Hansen exemplifies the spirit of innovation through her contributions to pharmaceutical sciences. Her dedication to developing stable formulations and her collaborative efforts with talented professionals continue to pave the way for advancements in healthcare.